Cite
Clinical Features and Prognostic Analysis of MuSK-Antibody-Positive Myasthenia Gravis versus Double-Seropositive Myasthenia Gravis: A Single-Center Study from Central South China.
MLA
He, Ting, et al. “Clinical Features and Prognostic Analysis of MuSK-Antibody-Positive Myasthenia Gravis versus Double-Seropositive Myasthenia Gravis: A Single-Center Study from Central South China.” Neuropsychiatric Disease & Treatment, vol. 20, Mar. 2024, pp. 725–35. EBSCOhost, https://doi.org/10.2147/NDT.S450651.
APA
He, T., Chen, K., Li, Y., Luo, Z., Luo, M., & Yang, H. (2024). Clinical Features and Prognostic Analysis of MuSK-Antibody-Positive Myasthenia Gravis versus Double-Seropositive Myasthenia Gravis: A Single-Center Study from Central South China. Neuropsychiatric Disease & Treatment, 20, 725–735. https://doi.org/10.2147/NDT.S450651
Chicago
He, Ting, Kangzhi Chen, Yi Li, Zhaohui Luo, Mengchuan Luo, and Huan Yang. 2024. “Clinical Features and Prognostic Analysis of MuSK-Antibody-Positive Myasthenia Gravis versus Double-Seropositive Myasthenia Gravis: A Single-Center Study from Central South China.” Neuropsychiatric Disease & Treatment 20 (March): 725–35. doi:10.2147/NDT.S450651.